MedPath

Metabolic Screening in Patients With Donnai-Barrow Syndrome

Completed
Conditions
Donnai-Barrow Syndrome
Registration Number
NCT01509287
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).

Detailed Description

The purpose of this study is to better understand the role of certain nutrients and vitamins in promoting the healthy development of individuals with Donnai-Barrow Syndrome. The investigators hope that the information gained by studying the metabolism of children with Donnai-Barrow Syndrome and their family members will lead to significant advances in the treatment of this disease.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria

All individuals affected with Donnai-Barrow Syndrome

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
measures of blood sugar, cholesterol, vitamins A and D, and other compounds5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath